MedTrace Logo

Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Revision Total Knee Arthroplasty

NCT03694925 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 156

Last updated 2020-12-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to investigate whether there are quantifiable differences in the level of calprotectin in the synovial fluid that allow separation of different modes of joint implant failure (e.g. infected, aseptic loosening). A subset of primary TKA patients (with history of OA) will be included as a baseline.

Conditions

  • Prosthetic Joint Infection

Interventions

DIAGNOSTIC_TEST

Calprotectin test

Calprotectin will be measured both by ELISA and point of care test.

Sponsors & Collaborators

  • The Cleveland Clinic

    lead OTHER

Principal Investigators

  • Carlos Higuera, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-29
Primary Completion
2020-01-07
Completion
2020-03-04

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03694925 on ClinicalTrials.gov